Jo IH, Ko SW. Acute cholangitis with Achromobacter xylosoxidans bacteremia after endoscopic retrograde cholangiopancreatography in hilar cholangiocarcinoma: A case report. World J Clin Cases 2024; 12(20): 4377-4383 [PMID: 39015928 DOI: 10.12998/wjcc.v12.i20.4377]
Corresponding Author of This Article
Sung Woo Ko, PhD, Professor, Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 1021, Tongil-ro, Eunpyeong-gu, Seoul 03312, South Korea. gogo930@catholic.ac.kr
Research Domain of This Article
Infectious Diseases
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Jul 16, 2024; 12(20): 4377-4383 Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4377
Acute cholangitis with Achromobacter xylosoxidans bacteremia after endoscopic retrograde cholangiopancreatography in hilar cholangiocarcinoma: A case report
Ik Hyun Jo, Sung Woo Ko
Ik Hyun Jo, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 16471, South Korea
Sung Woo Ko, Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, South Korea
Author contributions: SW Ko conducted the study design; SW Ko and IH Jo corrected the data; SW Ko created the table and figures; IH Jo was the gastroenterologist of the patient and contributed to the original manuscript drafting; SW Ko and IH Jo reviewed, edited, and approved the final manuscript.
Informed consent statement: Written informed consent was obtained from the patient for publication of this case report and any associated images.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sung Woo Ko, PhD, Professor, Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 1021, Tongil-ro, Eunpyeong-gu, Seoul 03312, South Korea. gogo930@catholic.ac.kr
Received: March 25, 2024 Revised: May 14, 2024 Accepted: May 27, 2024 Published online: July 16, 2024 Processing time: 98 Days and 5.8 Hours
Core Tip
Core Tip:Achromobacter xylosoxidans-induced biliary system infections has not been previously described. We present a rare cholangitis case after endoscopic retrograde cholangiopancreatography (ERCP) caused by A. xylosoxidans. Establishing adequate drainage for obstructed bile ducts during ERCP is essential to decrease the risk of post-ERCP cholangitis. In this case, cholangitis developed due to insufficient length of the biliary stent and was resolved by susceptible antibiotic administration and adequate biliary drainage at the second ERCP. As A. xylosoxidans-induced cholangitis has not been previously reported, the A. xylosoxidans contamination source remains unclear. Further investigation is needed to identify the colonization source and prevent endoscopy-associated infections.
